Cargando…

Structural and Genomic Insights Into Pyrazinamide Resistance in Mycobacterium tuberculosis Underlie Differences Between Ancient and Modern Lineages

Resistance to drugs used to treat tuberculosis disease (TB) continues to remain a public health burden, with missense point mutations in the underlying Mycobacterium tuberculosis bacteria described for nearly all anti-TB drugs. The post-genomics era along with advances in computational and structura...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tunstall, Tanushree, Phelan, Jody, Eccleston, Charlotte, Clark, Taane G., Furnham, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372558/ https://www.ncbi.nlm.nih.gov/pubmed/34422898 http://dx.doi.org/10.3389/fmolb.2021.619403

Ejemplares similares

Insights Into Mutations Induced Conformational Changes and Rearrangement of Fe(2+) Ion in pncA Gene of Mycobacterium tuberculosis to Decipher the Mechanism of Resistance to Pyrazinamide
por: Nangraj, Asma Sindhoo, et al.
Publicado: (2021)

Combining structure and genomics to understand antimicrobial resistance
por: Tunstall, Tanushree, et al.
Publicado: (2020)

Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis
por: Portelli, Stephanie, et al.
Publicado: (2018)

Gibbs Free Energy Calculation of Mutation in PncA and RpsA Associated With Pyrazinamide Resistance
por: Khan, Muhammad Tahir, et al.
Publicado: (2020)

Robust barcoding and identification of Mycobacterium tuberculosis lineages for epidemiological and clinical studies
por: Napier, Gary, et al.
Publicado: (2020)

Immunometabolism of Phagocytes During Mycobacterium tuberculosis Infection
por: Kumar, Ranjeet, et al.
Publicado: (2019)

Feature weighted models to address lineage dependency in drug-resistance prediction from Mycobacterium tuberculosis genome sequences
por: Billows, Nina, et al.
Publicado: (2023)

Pyrazinamide Resistance, Mycobacterium tuberculosis Lineage and Treatment Outcomes in San Francisco, California
por: Budzik, Jonathan M., et al.
Publicado: (2014)

Mixed infections in genotypic drug-resistant Mycobacterium tuberculosis
por: Wang, Linfeng, et al.
Publicado: (2023)

Control of Toxin-Antitoxin Systems by Proteases in Mycobacterium Tuberculosis
por: Bordes, Patricia, et al.
Publicado: (2021)

A Simple and Sensitive UPLC–UV Method for Simultaneous Determination of Isoniazid, Pyrazinamide, and Rifampicin in Human Plasma and Its Application in Therapeutic Drug Monitoring
por: Jiang, Zhimei, et al.
Publicado: (2022)

Crystal Structure of Mycobacterium tuberculosis Elongation Factor G1
por: Gao, Xiaopan, et al.
Publicado: (2021)

Comparison of in silico predicted Mycobacterium tuberculosis spoligotypes and lineages from whole genome sequencing data
por: Napier, Gary, et al.
Publicado: (2023)

Detection of Pyrazinamide Heteroresistance in Mycobacterium tuberculosis
por: Werngren, Jim, et al.
Publicado: (2021)

Phylogenetic analysis of vitamin B12-related metabolism in Mycobacterium tuberculosis
por: Young, Douglas B., et al.
Publicado: (2015)

Mycobacterium tuberculosis Uses Mce Proteins to Interfere With Host Cell Signaling
por: Fenn, Katherine, et al.
Publicado: (2020)

Application of Computational Methods in Understanding Mutations in Mycobacterium tuberculosis Drug Resistance
por: Mugumbate, Grace, et al.
Publicado: (2021)

Balanced activities of Hsp70 and the ubiquitin proteasome system underlie cellular protein homeostasis
por: Jawed, Areeb, et al.
Publicado: (2023)

Genome-wide analysis of Mycobacterium tuberculosis polymorphisms reveals lineage-specific associations with drug resistance
por: Oppong, Yaa E. A., et al.
Publicado: (2019)

Portable sequencing of Mycobacterium tuberculosis for clinical and epidemiological applications
por: Gómez-González, Paula J, et al.
Publicado: (2022)

An Ancient Residue Metabolomics-Based Method to Distinguish Use of Closely Related Plant Species in Ancient Pipes
por: Brownstein, Korey J., et al.
Publicado: (2020)

An Epistatic Network Describes oppA and glgB as Relevant Genes for Mycobacterium tuberculosis
por: Posada-Reyes, Ali-Berenice, et al.
Publicado: (2022)

Large-scale genomic analysis of Mycobacterium tuberculosis reveals extent of target and compensatory mutations linked to multi-drug resistant tuberculosis
por: Napier, Gary, et al.
Publicado: (2023)

Standing of nucleic acid testing strategies in veterinary diagnosis laboratories to uncover Mycobacterium tuberculosis complex members
por: Costa, Pedro, et al.
Publicado: (2014)

Methylation in Mycobacterium tuberculosis is lineage specific with associated mutations present globally
por: Phelan, Jody, et al.
Publicado: (2018)

pncA Large Deletion is the Characteristic of Pyrazinamide-Resistant Mycobacterium tuberculosis belonging to the East Asian Lineage
por: Kim, Na Yung, et al.
Publicado: (2023)

Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection
por: Manca, Claudia, et al.
Publicado: (2013)

Functional genetic variation in pe/ppe genes contributes to diversity in Mycobacterium tuberculosis lineages and potential interactions with the human host
por: Gómez-González, Paula Josefina, et al.
Publicado: (2023)

A snapshot of translation in Mycobacterium tuberculosis during exponential growth and nutrient starvation revealed by ribosome profiling
por: Sawyer, Elizabeth B., et al.
Publicado: (2021)

Mycobacterium tuberculosis Methyltransferase Rv1515c Can Suppress Host Defense Mechanisms by Modulating Immune Functions Utilizing a Multipronged Mechanism
por: Rani, Anshu, et al.
Publicado: (2022)

Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia
por: Sengstake, Sarah, et al.
Publicado: (2017)

A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance
por: Sheen, Patricia, et al.
Publicado: (2017)

Robust detection of point mutations involved in multidrug-resistant Mycobacterium tuberculosis in the presence of co-occurrent resistance markers
por: Libiseller-Egger, Julian, et al.
Publicado: (2020)

A modified decision tree approach to improve the prediction and mutation discovery for drug resistance in Mycobacterium tuberculosis
por: Deelder, Wouter, et al.
Publicado: (2022)

Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis
por: Ahmad, Zahoor, et al.
Publicado: (2012)

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001)

Mycobacterium tuberculosis Pyrazinamide Resistance Determinants: a Multicenter Study
por: Miotto, Paolo, et al.
Publicado: (2014)

The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD
por: Sun, Qingan, et al.
Publicado: (2020)

Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide
por: Santucci, Pierre, et al.
Publicado: (2021)

Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis
por: Modlin, Samuel J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t8ja0orop445olrh30fatq7u7g